SCHEMBL31663559

SCHEMBL31663559

Cc1cc(-c2ccc(-c3ccccc3)c(-c3ccccc3)c2C#N)cc(C)n1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.60
HPGD P15428 7/20 0.60
KDM4E B2RXH2 7/20 0.60
HSD17B10 Q99714 3/20 0.60
ADORA2A P29274 4/20 0.49
ADRA2A P08913 1/20 0.49
HTT P42858 1/20 0.49
ADORA1 P30542 3/20 0.48
SQOR Q9Y6N5 1/20 0.46
MAPK1 P28482 2/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
PPARG P37231 2/20 0.45
NPSR1 Q6W5P4 2/20 0.45
NCOA2 Q15596 1/20 0.45
NCOA1 Q15788 1/20 0.45
NCOA3 Q9Y6Q9 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.44
LMNA P02545 1/20 0.44
GLA P06280 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31663537 0.79 KDM4E (0.50) ALDH1A1HPGDKDM4EHSD17B10ADORA2A
SCHEMBL31663555 0.79 ADORA2A (0.44) ALDH1A1HPGDKDM4EHSD17B10ADORA2A
SCHEMBL31663596 0.78 ADORA1 (0.55) ALDH1A1HPGDKDM4EHSD17B10ADORA2A
SCHEMBL12679765 0.78 ADORA1 (0.55) ALDH1A1HPGDKDM4EHSD17B10ADORA2A
SCHEMBL31663594 0.78 ADORA1 (0.55) ALDH1A1HPGDKDM4EHSD17B10ADORA2A
SCHEMBL31663548 0.76 ALDH1A1 (0.49) ALDH1A1HPGDKDM4EHSD17B10ADORA2A
SCHEMBL11297837 0.75 KDM4E (1.00) ALDH1A1HPGDKDM4EHSD17B10ADORA2A
SCHEMBL14176622 0.74 KDM4E (0.77) ALDH1A1HPGDKDM4EHSD17B10ADORA2A
SCHEMBL31663541 0.74 KDM4E (0.58) ALDH1A1HPGDKDM4EHSD17B10ADORA2A
SCHEMBL31663521 0.74 ADORA1 (0.53) ALDH1A1HPGDKDM4EHSD17B10ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250359476-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX INC (JP) 2025-11-20 US disclosed
US-12369492-B2 Composition of matter for use in organic light-emitting diodes KYULUX, INC. (JP) 2025-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250359476-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES CRY2, SLCO1B3, NDUFV3 ALDH1A1 242/4885HPGD 2163/4885KDM4E 4364/4885
US-12369492-B2 Composition of matter for use in organic light-emitting diodes CRY2, SLCO1B3, NDUFV3 ALDH1A1 242/4885HPGD 2163/4885KDM4E 4364/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.